FDA and EMA Biosimilar Approvals.
Publication
, Journal Article
Jung, EH; Sarpatwari, A; Kesselheim, AS; Sinha, MS
Published in: Journal of general internal medicine
June 2020
Duke Scholars
Published In
Journal of general internal medicine
DOI
EISSN
1525-1497
ISSN
0884-8734
Publication Date
June 2020
Volume
35
Issue
6
Start / End Page
1908 / 1910
Related Subject Headings
- United States Food and Drug Administration
- United States
- Humans
- General & Internal Medicine
- Drug Approval
- Biosimilar Pharmaceuticals
- 4206 Public health
- 4203 Health services and systems
- 3202 Clinical sciences
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Jung, E. H., Sarpatwari, A., Kesselheim, A. S., & Sinha, M. S. (2020). FDA and EMA Biosimilar Approvals. Journal of General Internal Medicine, 35(6), 1908–1910. https://doi.org/10.1007/s11606-019-05408-6
Jung, Emily H., Ameet Sarpatwari, Aaron S. Kesselheim, and Michael S. Sinha. “FDA and EMA Biosimilar Approvals.” Journal of General Internal Medicine 35, no. 6 (June 2020): 1908–10. https://doi.org/10.1007/s11606-019-05408-6.
Jung EH, Sarpatwari A, Kesselheim AS, Sinha MS. FDA and EMA Biosimilar Approvals. Journal of general internal medicine. 2020 Jun;35(6):1908–10.
Jung, Emily H., et al. “FDA and EMA Biosimilar Approvals.” Journal of General Internal Medicine, vol. 35, no. 6, June 2020, pp. 1908–10. Epmc, doi:10.1007/s11606-019-05408-6.
Jung EH, Sarpatwari A, Kesselheim AS, Sinha MS. FDA and EMA Biosimilar Approvals. Journal of general internal medicine. 2020 Jun;35(6):1908–1910.
Published In
Journal of general internal medicine
DOI
EISSN
1525-1497
ISSN
0884-8734
Publication Date
June 2020
Volume
35
Issue
6
Start / End Page
1908 / 1910
Related Subject Headings
- United States Food and Drug Administration
- United States
- Humans
- General & Internal Medicine
- Drug Approval
- Biosimilar Pharmaceuticals
- 4206 Public health
- 4203 Health services and systems
- 3202 Clinical sciences
- 1103 Clinical Sciences